Home Blog Page 171

Blog

Pharma Marketing Blog

Random

Is Pharmaceutical Marketing BS?

Pharma Guy - May 23, 2005

Glaxo, Pull Your Imus Ads!

Pharma Guy - April 11, 2007

How Sales Reps Can Use Tablets to Fool Their Sales Manager...

Pharma Guy - September 7, 2011

Pharma Support for CME Slows

Pharma Guy - October 9, 2006

Retro Relpax Web Site Features Woman Mopping the Floor. Inspirational? Not!

Pharma Guy - August 23, 2012

FDA Urged to Take “Small Steps” in Developing Final Guidelines for...

Pharma Guy - March 21, 2013

FTC, Generics, and the War in Iraq

Pharma Guy - February 20, 2008

True Confessions Redux: Another MD Shill for Pharma Outed

Pharma Guy - November 28, 2007

Pharma: The Year 2012 in Images

Pharma Guy - December 15, 2012

Immutable Laws of DTC Domain Naming

Pharma Guy - March 3, 2006

1...170171172...241 Page 171 of 241

EDITOR PICKS

26th DTC National Conference

March 12, 2026

Informa Connect 2026 Events

January 19, 2026

FDA Pilots Are Changing Healthcare. Here’s What Pharma Marketers Should Do...

January 16, 2026

POPULAR POSTS

FDA Has Many Hurdles to Overcome in its Effort to Stem...

May 27, 2017

Advances in Genetic Medicine May Be Outpacing Some Clinicians’ Understanding, But...

December 21, 2020

Pharma Marketing News – Past Issues (2016)

January 1, 2017

RECENT POSTS

Pharmaceutical portfolio strategy concept showing connected drug products, analytics charts, and digital healthcare icons under a magnifying glass

The Portfolio Fragmentation Challenge: How Marketers Can Maintain a Clear Story...

April 24, 2026

Split image showing a stopwatch symbolizing speed and a compliance checklist with medical tools representing safety in pharma marketing

Speed vs Safety: How Pharma Marketers Can Compete in a Faster,...

April 23, 2026

Balance scale comparing pharmaceutical demand and clinical evidence with GLP-1 medications and research materials

The Demand–Evidence Gap: What GLP-1 Growth Teaches Pharma Marketers About Responsible...

April 22, 2026